Artesunate Exerts a Direct Effect on Endothelial Cell Activation and NF-κB Translocation in a Mechanism Independent of Plasmodium Killing. (11th October 2012)

• Record Type: Journal Article
• Authors: Souza, Mariana C.; Paixão, Flávio Henrique Marcolino; Ferraris, Fausto K.; Ribeiro, Isabela; Henriques, Maria das Graças M. O.
• Other Names: Wahlgren Mats Academic Editor.
• Is Part Of: Malaria research and treatment. Volume 2012(2012)
• Publication Date: 2012-10-11
• Subjects: Malaria -- Periodicals; Malaria -- Research -- Periodicals; Malaria -- Treatment -- Periodicals; Malaria -- Prevention -- Periodicals; 616.9362005
• DOI: 10.1155/2012/679090
• Languages: English
• ISSNs: 2090-8075

Abstract

Abstract : Artemisinin and its derivates are an important class of antimalarial drug and are described to possess immunomodulatory activities. Few studies have addressed the effect of artesunate in the murine malaria model or its effect on host immune response during malaria infection. Herein, we study the effect of artesunate treatment and describe an auxiliary mechanism of artesunate in modulating the inflammatory response during experimental malaria infection in mice. Treatment with artesunate did not reduce significantly the parasitemia within 12 h, however, reduced BBB breakdown and TNF- α mRNA expression in the brain tissue of artesunate-treated mice. Conversely, mefloquine treatment was not able to alter clinical features. Notably, artesunate pretreatment failed to modulate the expression of LFA-1 in splenocytes stimulated with parasitized red blood cells (pRBCs) in vitro ; however, it abrogated the expression of ICAM-1 in pRBC-stimulated endothelial cells. Accordingly, a cytoadherence in vitro assay demonstrated that pRBCs did not adhere to artesunate-treated vascular endothelial cells. In addition, NF- κ B nuclear translocation in endothelial cells stimulated with pRBCs was impaired by artesunate treatment. Our results suggest that artesunate is able to exert a protective effect against the P. berghei -induced inflammatory response by inhibiting NF- κ B nuclear translocation and the subsequent expression of ICAM-1.